1-[2-bromo-pyridin-4-yl]-2-[6-methyl-pyridin-2-yl]-ethanone 、 4-甲酰基苯硼酸 、 以to give the title compound as a yellow solid (2.1 g, 96.69%)的产率得到2-(6-methylpyridin-2-yl)-1-[2-(4-formylphenyl)-pyridin-4-yl]-ethanone
Pyrazole inhibitors of the transforming growth factor
申请人:Gellibert Jeanne Francoise
公开号:US20060058329A1
公开(公告)日:2006-03-16
The invention relates to novel pyrazole derivatives which are inhibitors of the transforming growth factor, (“TGF”)-β signalling pathway, in particular, the phosphorylation of smad2 or smad3 by the TGF-β type I or activin-like kinase (“ALK”)-5 receptor, methods for their preparation and their use in medicine, specifically in the treatment and prevention of a disease state mediated by this pathway.
[EN] 2-PHENYLPYRIDIN-4-YL DERIVATIVES AS ALK5 INHIBITORS<br/>[FR] DERIVES DE C2-PHENYLPYRIDINE-4-YL EN TANT QU'INHIBITEURS D'ALK5
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2004013135A1
公开(公告)日:2004-02-12
This invention relates to novel 2-phenylpyridin-4-yl heterocyclyl derivatives which are inhibitors of the transforming growth factor, ('TGF')-ß signalling pathway, in particular, the phosphorylation of smad2 or smad3 by the TGF-β type I or activin-like kinase ('ALK')-5 receptor, methods for their preparation and their use in medicine, specifically in the treatment and prevention of a disease state mediated by this pathway.
The invention relates to novel aminothiazole derivatives which are inhibitors of the transforming growth factor, (“TGF”)-β signalling pathway, in particular, the phosphorylation of smad2 or smad3 by the TGF-β type I or activin-like kinase (“ALK”)-5 receptor, methods for their preparation and their use in medicine, specifically in the treatment and prevention of a disease state mediated by this pathway.